These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 2683920

  • 1. The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia.
    Ganser A, Ottmann OG, Erdmann H, Schulz G, Hoelzer D.
    Ann Intern Med; 1989 Dec 01; 111(11):887-92. PubMed ID: 2683920
    [Abstract] [Full Text] [Related]

  • 2. Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy.
    Lieschke GJ, Maher D, Cebon J, O'Connor M, Green M, Sheridan W, Boyd A, Rallings M, Bonnem E, Metcalf D.
    Ann Intern Med; 1989 Mar 01; 110(5):357-64. PubMed ID: 2644886
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.
    Welte K, Zeidler C, Reiter A, Müller W, Odenwald E, Souza L, Riehm H.
    Blood; 1990 Mar 01; 75(5):1056-63. PubMed ID: 1689595
    [Abstract] [Full Text] [Related]

  • 4. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
    Antman KS, Griffin JD, Elias A, Socinski MA, Ryan L, Cannistra SA, Oette D, Whitley M, Frei E, Schnipper LE.
    N Engl J Med; 1988 Sep 08; 319(10):593-8. PubMed ID: 3045544
    [Abstract] [Full Text] [Related]

  • 5. Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.
    Gianni AM, Bregni M, Siena S, Orazi A, Stern AC, Gandola L, Bonadonna G.
    J Clin Oncol; 1990 May 08; 8(5):768-78. PubMed ID: 2185337
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
    Lieschke GJ, Maher D, O'Connor M, Green M, Sheridan W, Rallings M, Bonnem E, Burgess AW, McGrath K, Fox RM.
    Cancer Res; 1990 Feb 01; 50(3):606-14. PubMed ID: 2404573
    [Abstract] [Full Text] [Related]

  • 8. Clinical studies with recombinant human granulocyte-macrophage colony-stimulating factor.
    Steward WP, Scarffe JH, Bonnem E, Crowther D.
    Int J Cell Cloning; 1990 Jan 01; 8 Suppl 1():335-46. PubMed ID: 2182743
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Congenital neutropenia: a case study.
    Daghistani D, Jimenez JJ, Toledano SR, Cirocco RE, Yunis AA.
    Am J Pediatr Hematol Oncol; 1990 Jan 01; 12(2):210-4. PubMed ID: 1696074
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo action of recombinant human GM-CSF (rhGM-CSF) in patients with myelodysplastic syndromes.
    Hoelzer D, Ganser A, Völkers B, Greher J, Walther F.
    Blood Cells; 1988 Jan 01; 14(2-3):551-9. PubMed ID: 3067785
    [Abstract] [Full Text] [Related]

  • 12. Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials.
    Nissen-Druey C.
    Nouv Rev Fr Hematol (1978); 1989 Jan 01; 31(2):99-101. PubMed ID: 2475852
    [No Abstract] [Full Text] [Related]

  • 13. Recombinant human granulocyte-macrophage colony-stimulating factor in acquired or chemotherapy-induced neutropenia. An open clinical trial.
    Piguet D, Chapuis B.
    Acta Oncol; 1994 Jan 01; 33(6):639-43. PubMed ID: 7946441
    [Abstract] [Full Text] [Related]

  • 14. Differential effect of GM-CSF and G-CSF in cyclic neutropenia.
    Freund MR, Luft S, Schöber C, Heussner P, Schrezenmaier H, Porzsolt F, Welte K.
    Lancet; 1990 Aug 04; 336(8710):313. PubMed ID: 1695985
    [No Abstract] [Full Text] [Related]

  • 15. [Changes in neutrophil counts and functions after the administration of recombinant human granulocyte colony-stimulating factor in a patient with chronic idiopathic neutropenia].
    Sai M, Kawanishi Y, Kuriyama K, Kuratsuji T, Toyama K.
    Rinsho Ketsueki; 1990 Apr 04; 31(4):484-6. PubMed ID: 1696326
    [Abstract] [Full Text] [Related]

  • 16. Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy.
    Herrmann F, Schulz G, Wieser M, Kolbe K, Nicolay U, Noack M, Lindemann A, Mertelsmann R.
    Am J Med; 1990 Jun 04; 88(6):619-24. PubMed ID: 2189305
    [Abstract] [Full Text] [Related]

  • 17. Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) following autologous marrow transplantation in man.
    Appelbaum FR, Nemunaitis J.
    Behring Inst Mitt; 1988 Aug 04; (83):145-8. PubMed ID: 3071330
    [Abstract] [Full Text] [Related]

  • 18. Intervention treatment of established neutropenia with human recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in patients undergoing cancer chemotherapy.
    Gerhartz HH, Stern AC, Wolf-Hornung B, Kazempour M, Schmetzer H, Gugerli U, Jones TC, Wilmanns W.
    Leuk Res; 1993 Feb 04; 17(2):175-85. PubMed ID: 8429694
    [Abstract] [Full Text] [Related]

  • 19. Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy.
    Herrmann F, Schulz G, Wieser M, Kolbe K, Nicolay U, Noack M, Lindemann A, Mertelsmann R.
    Haematol Blood Transfus; 1990 Feb 04; 33():717-23. PubMed ID: 2182461
    [Abstract] [Full Text] [Related]

  • 20. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
    Bilgin K, Yaramiş A, Haspolat K, Taş MA, Günbey S, Derman O.
    Pediatrics; 2001 Jan 04; 107(1):36-41. PubMed ID: 11134431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.